Ignite Creation Date:
2025-12-25 @ 5:00 AM
Ignite Modification Date:
2026-05-10 @ 3:22 PM
Study NCT ID:
NCT04441918
Status:
UNKNOWN
Last Update Posted:
2020-06-22
First Post:
2020-06-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects
Sponsor:
Shanghai Junshi Bioscience Co., Ltd.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
JS016-001-I
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None